Form 4: InMed Pharmaceuticals Insider Buys Shares
Insider Transaction (Form 4)
ADAR1 Capital Management, LLC and 1 other reported changes in beneficial ownership of InMed Pharmaceuticals Inc. common stock on July 15, 2026.
Summary
- Open-market purchase: acquired 1,000 Common Shares at $1.55 ($1,555) on July 15, 2026; holds 801,000 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $1,555, committing personal capital to the stock.
Insider Transactions
ADAR1 Capital Management, LLC — 10% owner
Daniel Schneeberger — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Open-market purchase | Common Shares | 1,000 | $2 | $1.6K | 801,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Open-market purchase (1,000 shares) |
Keywords
insider transaction, Form 4, INM, InMed Pharmaceuticals Inc., bullish, ADAR1 Capital Management, LLC, Daniel Schneeberger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.